Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Fosaprepitant Dimeglumine Patent Expiration

Fosaprepitant Dimeglumine was first introduced by Merck And Co Inc in its drug Emend on Jan 25, 2008. Other drugs containing Fosaprepitant Dimeglumine are Fosaprepitant Dimeglumine, Focinvez. 21 different companies have introduced drugs containing Fosaprepitant Dimeglumine.


Fosaprepitant Dimeglumine Patents

Given below is the list of patents protecting Fosaprepitant Dimeglumine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Focinvez US11065256 Administration and dosage of diaminophenothiazines Jan 11, 2039 Steriscience
Focinvez US11065265 Compositions of fosaprepitant and methods of preparation Jan 11, 2039 Steriscience
Focinvez US12042504 Injectable fosaprepitant composition Jan 11, 2039 Steriscience
Emend US5691336

(Pediatric)

 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists Sep 04, 2019

(Expired)

 Merck And Co Inc
Emend US5691336 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists Mar 04, 2019

(Expired)

 Merck And Co Inc
Emend US5716942 Treatment of migraine with morpholine tachykinin receptor antagonists Feb 10, 2015

(Expired)

 Merck And Co Inc
Emend US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists Mar 04, 2014

(Expired)

 Merck And Co Inc
Emend US5538982 Medical use for tachykinin antagonists Jul 23, 2013

(Expired)

 Merck And Co Inc
Emend US7214692 Medical use for tachykinin antagonists Sep 18, 2012

(Expired)

 Merck And Co Inc



Fosaprepitant Dimeglumine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fosaprepitant Dimeglumine Generic API Manufacturers

Several generic applications have been filed for Fosaprepitant Dimeglumine. The first generic version for Fosaprepitant Dimeglumine was by Fresenius Kabi Usa Llc and was approved on Jun 9, 2016. And the latest generic version is by Piramal Critical Care Inc and was approved on May 16, 2023.

Given below is the list of companies who have filed for Fosaprepitant Dimeglumine generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Aug 26, 2020





2. APOTEX

Apotex Inc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Sep 5, 2019


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Winnipeg Apotex Fermentation Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Brantford Apotex Pharmachem Inc.
India
Bengaluru Apotex Research Private Limited
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bangalore Apotex Pharmachem India Pvt Ltd.





3. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Jul 29, 2021


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





4. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 5, 2019





5. BE PHARMS

Be Pharmaceuticals Ag has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Be Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 5, 2019





6. CHIA TAI TIANQING

Chia Tai Tianqing Pharmaceutical Group Co Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Chia Tai Tianqing.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Mar 3, 2021


Manufacturing Plant Locations
New

Chia Tai Tianqing's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Chia Tai Tianqing as present at those locations.

Country City Firm Name
China
Lianyungang Chia Tai Tianqing Pharmaceutical Group Co., Ltd.





7. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Dec 9, 2020





8. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Jan 12, 2021


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited





9. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Jun 9, 2016


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Grand Island Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Lake Zurich Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)





10. GENEYORK PHARMS

Geneyork Pharmaceuticals Group Llc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Geneyork Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Sep 5, 2019





11. LUPIN LTD

Lupin Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 5, 2019


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





12. MSN

Msn Laboratories Private Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 5, 2019


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Sangareddy MSN Laboratories Private Limited, R&D Center
Isnapur MSN Laboratories Private Limited, Unit-II
Sangareddy MSN Laboratories Private Ltd.
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Sangareddy MSN Pharmachem Private Limited
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
Rangareddy District MSN Laboratories Private Limited
Yadadri Bhuvanagiri District MSN Organics Private Limited
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Kamareddy MSN Life Sciences Private Limited
United States
Piscataway MSN PHARMACEUTICALS INC





13. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 2 different strengths of generic version for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 115MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Sep 5, 2019
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 5, 2019





14. NAVINTA LLC

Navinta Llc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Navinta Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Aug 20, 2020





15. PIRAMAL CRITICAL

Piramal Critical Care Inc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Piramal Critical.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A May 16, 2023


Manufacturing Plant Locations
New

Piramal Critical's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Piramal Critical as present at those locations.

Country City Firm Name
United States
Bethlehem Piramal Critical Care, Inc.





16. PRAXGEN

Praxgen Pharmaceuticals Llc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Praxgen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Oct 4, 2021


Manufacturing Plant Locations
New

Praxgen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Praxgen as present at those locations.

Country City Firm Name
United States
Monmouth Junction Praxgen Pharmaceuticals, LLC





17. QILU PHARM HAINAN

Qilu Pharmaceutical Hainan Co Ltd has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Prescription INTRAVENOUS AP Sep 8, 2020





18. SANDOZ

Sandoz Inc has filed for 1 generic for Fosaprepitant Dimeglumine. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 150MG BASE/VIAL

powder Discontinued INTRAVENOUS N/A Dec 8, 2020


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited